It’s no surprise that Q318 US revenue growth accelerated YoY when, for the same period last year, the US Total Joints Market experienced major market disruption from two major hurricanes which delayed procedures beyond the usual Q3 procedural slowdown. Industry analysts, including Cantor Fitzgerald’s Craig Bijou, report that US recon growth was relatively flat on a stacked two-year basis. From this perspective, SmartTRAK believes this trend confirms the market is not showing major signs of improvement or decline...
Among the many topics covered in detail in the Q318 Total Joints Market Recap are:
- Pricing Pressure Worsens
- Knee Share Shifts on Robotics
- Stable Hip Shares with Improved Growth Overall
- Q318 Regulatory Highlights
While the US Hip Market did not see large shifts in share sequentially, several market players experienced improvement in Hip growth during the quarter. Growth drivers in the Hip Market varied. Zimmer Biomet reported...
*This article can only be viewed by SmartTRAK subscribers to this module. For information on how to subscribe, please click the button below.